Astex Pharmaceuticals™ has established a strong pipeline of small molecule, molecularly targeted drugs. SGI-110 and AT13387 are prioritized and advancing in multiple, potential indications.
Program / Mechanism / Indication
Partnered Products and Programs
Astex’s partners are advancing several Astex compounds in phase 1 clinical trials. These trials are completely funded and executed by our partners.
Compound Name / Mechanism